Company attributes
Other attributes
Alexion Pharmaceuticals is a biopharmaceutical company that is developing and commercializing therapeutic products for rare diseases.
The company's mission is to transform the lives of people that are affected by rare diseases and devastating conditions by innovating and creating meaningful value in all that it does.
The company continues to deepen its understanding of rare disease, which started with its pioneering work in complement biology, and the knowledge allows Alexion to innovate and evolve into new areas where there are high unmet needs and opportunities to help patients and families live their best lives.
The company has delivered transformative medicines for people with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), anti-aquaporin-4 (AQP4) antibody-positive neuromyelitis optica spectrum disorder (NMOSD), generalized Myasthenia Gravis (gMG), hypophosphatasia (HPP), and lysosomal acid lipase deficiency (LAL-D).
